Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2024

Open Access 01-12-2024 | Research

Association between the triglyceride-glucose index and impaired cardiovascular fitness in non-diabetic young population

Authors: Dachuan Guo, Zhenguo Wu, Fei Xue, Sha Chen, Xiangzhen Ran, Cheng Zhang, Jianmin Yang

Published in: Cardiovascular Diabetology | Issue 1/2024

Login to get access

Abstract

Background

The triglyceride-glucose (TyG) index has been linked to the onset, progression, and prognosis of cardiovascular disease (CVD) in middle-aged and elderly individuals. Nevertheless, the relationship between the TyG index and impaired cardiovascular fitness (CVF) remains unexplored in non-diabetic young population.

Methods

We used data from the National Health and Nutrition Examination Survey (NHANES) study (1999–2004) to conduct a cross-sectional study of 3364 participants who completed an examination of CVF. Impaired CVF was defined as low and moderate CVF levels determined by estimated maximal oxygen consumption (Vo2max), based on sex- and age-specific criteria. The TyG index was calculated by \(Ln[TG(mg/dL)\times FPG(mg/dl)/2]\).

Results

The age (median with interquartile range) of the study population was 28 (19–37) years, and the TyG index (median ± standard deviation) was 8.36 ± 0.52. A significant association between the TyG index and impaired CVF was found in multivariable logistical regression analysis (per 1-unit increase in the TyG index: OR, 1.46; 95% Cl 1.13–1.90). A dose‒response relationship between the TyG index and impaired CVF was presented by restricted cubic splines (RCS). A significant interaction (p = 0.027) between sex and the TyG index for impaired CVF was found in the population aged < 20 years.

Conclusions

In non-diabetic young population, individuals with higher TyG index values are at an increased likelihood of encountering impaired CVF. Furthermore, sex may exert an impact on CVF, as males tend to be more susceptible to impaired CVF under comparable TyG index conditions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020. 396(10258): 1204–1222. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020. 396(10258): 1204–1222.
2.
go back to reference Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the american heart association. Circulation. 2023;147(8):e93–621.PubMedCrossRef Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the american heart association. Circulation. 2023;147(8):e93–621.PubMedCrossRef
3.
go back to reference Ross R, Blair SN, Arena R, et al. Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a scientific statement from the american heart association. Circulation. 2016;134(24):e653–99.PubMedCrossRef Ross R, Blair SN, Arena R, et al. Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a scientific statement from the american heart association. Circulation. 2016;134(24):e653–99.PubMedCrossRef
4.
go back to reference Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009;301(19):2024–35.PubMedCrossRef Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009;301(19):2024–35.PubMedCrossRef
5.
go back to reference Mora S, Redberg RF, Cui Y, et al. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA. 2003;290(12):1600–7.PubMedCrossRef Mora S, Redberg RF, Cui Y, et al. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA. 2003;290(12):1600–7.PubMedCrossRef
6.
go back to reference Balady GJ, Arena R, Sietsema K, et al. Clinician’s Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122(2):191–225.PubMedCrossRef Balady GJ, Arena R, Sietsema K, et al. Clinician’s Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122(2):191–225.PubMedCrossRef
7.
go back to reference Guazzi M, Adams V, Conraads V, et al. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012;126(18):2261–74.PubMedPubMedCentralCrossRef Guazzi M, Adams V, Conraads V, et al. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012;126(18):2261–74.PubMedPubMedCentralCrossRef
8.
go back to reference Myers J, Arena R, Franklin B, et al. Recommendations for clinical exercise laboratories: a scientific statement from the american heart association. Circulation. 2009;119(24):3144–61.PubMedCrossRef Myers J, Arena R, Franklin B, et al. Recommendations for clinical exercise laboratories: a scientific statement from the american heart association. Circulation. 2009;119(24):3144–61.PubMedCrossRef
9.
go back to reference Myers J, Forman DE, Balady GJ, et al. Supervision of exercise testing by nonphysicians: a scientific statement from the American Heart Association. Circulation. 2014;130(12):1014–27.PubMedPubMedCentralCrossRef Myers J, Forman DE, Balady GJ, et al. Supervision of exercise testing by nonphysicians: a scientific statement from the American Heart Association. Circulation. 2014;130(12):1014–27.PubMedPubMedCentralCrossRef
10.
go back to reference Kaminsky LA, Arena R, Beckie TM, et al. The importance of cardiorespiratory fitness in the United States: the need for a national registry: a policy statement from the American Heart Association. Circulation. 2013;127(5):652–62.PubMedCrossRef Kaminsky LA, Arena R, Beckie TM, et al. The importance of cardiorespiratory fitness in the United States: the need for a national registry: a policy statement from the American Heart Association. Circulation. 2013;127(5):652–62.PubMedCrossRef
11.
go back to reference Liu X, Tan Z, Huang Y, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124.PubMedPubMedCentralCrossRef Liu X, Tan Z, Huang Y, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124.PubMedPubMedCentralCrossRef
12.
go back to reference Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76.PubMedPubMedCentralCrossRef Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76.PubMedPubMedCentralCrossRef
13.
go back to reference Wu Z, Liu L, Wang W, et al. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study. Cardiovasc Diabetol. 2022;21(1):142.PubMedPubMedCentralCrossRef Wu Z, Liu L, Wang W, et al. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study. Cardiovasc Diabetol. 2022;21(1):142.PubMedPubMedCentralCrossRef
14.
go back to reference Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17(1):83.PubMedPubMedCentralCrossRef Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17(1):83.PubMedPubMedCentralCrossRef
15.
go back to reference Liu L, Wu Z, Zhuang Y, et al. Association of triglyceride-glucose index and traditional risk factors with cardiovascular disease among non-diabetic population: a 10-year prospective cohort study. Cardiovasc Diabetol. 2022;21(1):256.PubMedPubMedCentralCrossRef Liu L, Wu Z, Zhuang Y, et al. Association of triglyceride-glucose index and traditional risk factors with cardiovascular disease among non-diabetic population: a 10-year prospective cohort study. Cardiovasc Diabetol. 2022;21(1):256.PubMedPubMedCentralCrossRef
16.
go back to reference ElSayed NA, Aleppo G, Aroda VR, et al. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care. 2023;46:19–40.CrossRef ElSayed NA, Aleppo G, Aroda VR, et al. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care. 2023;46:19–40.CrossRef
17.
go back to reference Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51.PubMedCrossRef Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51.PubMedCrossRef
18.
go back to reference Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433–8.PubMedCrossRef Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433–8.PubMedCrossRef
19.
go back to reference Park K, Ahn CW, Lee SB, et al. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 2019;42(8):1569–73.PubMedCrossRef Park K, Ahn CW, Lee SB, et al. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 2019;42(8):1569–73.PubMedCrossRef
20.
go back to reference Lu YW, Chang CC, Chou RH, et al. Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study. Cardiovasc Diabetol. 2021;20(1):206.PubMedPubMedCentralCrossRef Lu YW, Chang CC, Chou RH, et al. Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study. Cardiovasc Diabetol. 2021;20(1):206.PubMedPubMedCentralCrossRef
21.
go back to reference Wu S, Xu L, Wu M, Chen S, Wang Y, Tian Y. Association between triglyceride-glucose index and risk of arterial stiffness: a cohort study. Cardiovasc Diabetol. 2021;20(1):146.PubMedPubMedCentralCrossRef Wu S, Xu L, Wu M, Chen S, Wang Y, Tian Y. Association between triglyceride-glucose index and risk of arterial stiffness: a cohort study. Cardiovasc Diabetol. 2021;20(1):146.PubMedPubMedCentralCrossRef
22.
go back to reference Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–32.PubMedCrossRef Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–32.PubMedCrossRef
23.
go back to reference Levitzky YS, Pencina MJ, D’Agostino RB, et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol. 2008;51(3):264–70.PubMedCrossRef Levitzky YS, Pencina MJ, D’Agostino RB, et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol. 2008;51(3):264–70.PubMedCrossRef
24.
go back to reference Tiano JP, Mauvais-Jarvis F. Importance of oestrogen receptors to preserve functional β-cell mass in diabetes. Nat Rev Endocrinol. 2012;8(6):342–51.PubMedCrossRef Tiano JP, Mauvais-Jarvis F. Importance of oestrogen receptors to preserve functional β-cell mass in diabetes. Nat Rev Endocrinol. 2012;8(6):342–51.PubMedCrossRef
25.
go back to reference Stevenson JC, Crook D, Godsland IF, Collins P, Whitehead MI. Hormone replacement therapy and the cardiovascular system. Nonlipid effects Drugs. 1994;47(Suppl 2):35–41.PubMed Stevenson JC, Crook D, Godsland IF, Collins P, Whitehead MI. Hormone replacement therapy and the cardiovascular system. Nonlipid effects Drugs. 1994;47(Suppl 2):35–41.PubMed
26.
go back to reference Peters HW, Westendorp IC, Hak AE, et al. Menopausal status and risk factors for cardiovascular disease. J Intern Med. 1999;246(6):521–8.PubMedCrossRef Peters HW, Westendorp IC, Hak AE, et al. Menopausal status and risk factors for cardiovascular disease. J Intern Med. 1999;246(6):521–8.PubMedCrossRef
27.
go back to reference Melmed S. Pathogenesis and diagnosis of growth hormone deficiency in adults. N Engl J Med. 2019;380(26):2551–62.PubMedCrossRef Melmed S. Pathogenesis and diagnosis of growth hormone deficiency in adults. N Engl J Med. 2019;380(26):2551–62.PubMedCrossRef
28.
go back to reference Khan AS, Sane DC, Wannenburg T, Sonntag WE. Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system. Cardiovasc Res. 2002;54(1):25–35.PubMedCrossRef Khan AS, Sane DC, Wannenburg T, Sonntag WE. Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system. Cardiovasc Res. 2002;54(1):25–35.PubMedCrossRef
29.
go back to reference Duerr RL, McKirnan MD, Gim RD, Clark RG, Chien KR, Ross J Jr. Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation. 1996;93(12):2188–96.PubMedCrossRef Duerr RL, McKirnan MD, Gim RD, Clark RG, Chien KR, Ross J Jr. Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation. 1996;93(12):2188–96.PubMedCrossRef
30.
go back to reference Cao JM, Ong H, Chen C. Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system. Trends Endocrinol Metab. 2006;17(1):13–8.PubMedCrossRef Cao JM, Ong H, Chen C. Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system. Trends Endocrinol Metab. 2006;17(1):13–8.PubMedCrossRef
31.
go back to reference Mongraw-Chaffin M, Foster MC, Anderson C, et al. Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2018;71(17):1857–65.PubMedPubMedCentralCrossRef Mongraw-Chaffin M, Foster MC, Anderson C, et al. Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2018;71(17):1857–65.PubMedPubMedCentralCrossRef
32.
go back to reference Ostman C, Smart NA, Morcos D, Duller A, Ridley W, Jewiss D. The effect of exercise training on clinical outcomes in patients with the metabolic syndrome: a systematic review and meta-analysis. Cardiovasc Diabetol. 2017;16(1):110.PubMedPubMedCentralCrossRef Ostman C, Smart NA, Morcos D, Duller A, Ridley W, Jewiss D. The effect of exercise training on clinical outcomes in patients with the metabolic syndrome: a systematic review and meta-analysis. Cardiovasc Diabetol. 2017;16(1):110.PubMedPubMedCentralCrossRef
33.
go back to reference O’Donoghue G, Blake C, Cunningham C, Lennon O, Perrotta C. What exercise prescription is optimal to improve body composition and cardiorespiratory fitness in adults living with obesity? A network meta-analysis. Obes Rev. 2021;22(2):e13137.PubMedCrossRef O’Donoghue G, Blake C, Cunningham C, Lennon O, Perrotta C. What exercise prescription is optimal to improve body composition and cardiorespiratory fitness in adults living with obesity? A network meta-analysis. Obes Rev. 2021;22(2):e13137.PubMedCrossRef
35.
go back to reference Yavropoulou MP, Pikilidou M, Pantelidou D, Tsalikakis DG, Mousiolis A, Chalkia P, Yovos JG, Zebekakis P. Insulin secretion and resistance in normoglycemic patients with sickle cell disease. Hemoglobin. 2017;41(1):6–11.PubMedCrossRef Yavropoulou MP, Pikilidou M, Pantelidou D, Tsalikakis DG, Mousiolis A, Chalkia P, Yovos JG, Zebekakis P. Insulin secretion and resistance in normoglycemic patients with sickle cell disease. Hemoglobin. 2017;41(1):6–11.PubMedCrossRef
36.
go back to reference Wang L, Cong HL, Zhang JX, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80.PubMedPubMedCentralCrossRef Wang L, Cong HL, Zhang JX, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80.PubMedPubMedCentralCrossRef
37.
go back to reference Wang X, Xu W, Song Q, et al. Association between the triglyceride-glucose index and severity of coronary artery disease. Cardiovasc Diabetol. 2022;21(1):168.PubMedPubMedCentralCrossRef Wang X, Xu W, Song Q, et al. Association between the triglyceride-glucose index and severity of coronary artery disease. Cardiovasc Diabetol. 2022;21(1):168.PubMedPubMedCentralCrossRef
38.
go back to reference Wang A, Tian X, Zuo Y, et al. Change in triglyceride-glucose index predicts the risk of cardiovascular disease in the general population: a prospective cohort study. Cardiovasc Diabetol. 2021;20(1):113.PubMedPubMedCentralCrossRef Wang A, Tian X, Zuo Y, et al. Change in triglyceride-glucose index predicts the risk of cardiovascular disease in the general population: a prospective cohort study. Cardiovasc Diabetol. 2021;20(1):113.PubMedPubMedCentralCrossRef
39.
go back to reference Montoye HJ, Gayle R, Higgins M. Smoking habits, alcohol consumption and maximal oxygen uptake. Med Sci Sports Exerc. 1980;12(5):316–21.PubMedCrossRef Montoye HJ, Gayle R, Higgins M. Smoking habits, alcohol consumption and maximal oxygen uptake. Med Sci Sports Exerc. 1980;12(5):316–21.PubMedCrossRef
40.
go back to reference Ingemann-Hansen T, Halkjaer-Kristensen J. Cigarette smoking and maximal oxygen consumption rate in humans. Scand J Clin Lab Invest. 1977;37(2):143–8.PubMedCrossRef Ingemann-Hansen T, Halkjaer-Kristensen J. Cigarette smoking and maximal oxygen consumption rate in humans. Scand J Clin Lab Invest. 1977;37(2):143–8.PubMedCrossRef
41.
go back to reference Meijnikman AS, De Block C, Dirinck E, Verrijken A, Mertens I, Corthouts B, Van Gaal LF. Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population. Int J Obes (Lond). 2017;41(11):1615–20.PubMedCrossRef Meijnikman AS, De Block C, Dirinck E, Verrijken A, Mertens I, Corthouts B, Van Gaal LF. Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population. Int J Obes (Lond). 2017;41(11):1615–20.PubMedCrossRef
42.
go back to reference Gonzalez A, Deng Y, Lane AN, Benkeser D, Cui X, Staimez LR, Ford CN, Khan FN, Markley Webster SC, Leong A, et al. Impact of mismatches in HbA(1c) vs glucose values on the diagnostic classification of diabetes and prediabetes. Diabet Med. 2020;37(4):689–96.PubMedCrossRef Gonzalez A, Deng Y, Lane AN, Benkeser D, Cui X, Staimez LR, Ford CN, Khan FN, Markley Webster SC, Leong A, et al. Impact of mismatches in HbA(1c) vs glucose values on the diagnostic classification of diabetes and prediabetes. Diabet Med. 2020;37(4):689–96.PubMedCrossRef
43.
go back to reference Peterman JE, Harber MP, Imboden MT, Whaley MH, Fleenor BS, Myers J, Arena R, Kaminsky LA. Accuracy of exercise-based equations for estimating cardiorespiratory fitness. Med Sci Sports Exerc. 2021;53(1):74–82.PubMedCrossRef Peterman JE, Harber MP, Imboden MT, Whaley MH, Fleenor BS, Myers J, Arena R, Kaminsky LA. Accuracy of exercise-based equations for estimating cardiorespiratory fitness. Med Sci Sports Exerc. 2021;53(1):74–82.PubMedCrossRef
44.
go back to reference Smith AE, Evans H, Parfitt G, Eston R, Ferrar K. Submaximal exercise-based equations to predict maximal oxygen uptake in older adults: a systematic review. Arch Phys Med Rehabil. 2016;97(6):1003–12.PubMedCrossRef Smith AE, Evans H, Parfitt G, Eston R, Ferrar K. Submaximal exercise-based equations to predict maximal oxygen uptake in older adults: a systematic review. Arch Phys Med Rehabil. 2016;97(6):1003–12.PubMedCrossRef
Metadata
Title
Association between the triglyceride-glucose index and impaired cardiovascular fitness in non-diabetic young population
Authors
Dachuan Guo
Zhenguo Wu
Fei Xue
Sha Chen
Xiangzhen Ran
Cheng Zhang
Jianmin Yang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2024
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-023-02089-8

Other articles of this Issue 1/2024

Cardiovascular Diabetology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine